Global Targeted Therapy Market Report (2021 to 2028) - Size, Share, Outlook, and Opportunity Analysis
Targeted Therapy Market
Dublin, April 28, 2022 (GLOBE NEWSWIRE) -- The "Targeted Therapy Market, by Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
Targeted therapy is used individually and in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy. It is the foundation of precision medicine. Targeted therapies are divided into two classes such as small molecule medicines and monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells. Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab.
Most types of targeted therapies help to treat cancer by interfering with specific proteins that help tumors grow and spread throughout the body. They treat cancer in many ways such as helps the immune system destroy cancer cells, stop cancer cells from growing, stop signals that help form blood vessels, cause cancer cell death, deliver cell-killing substances to cancer cells, starve cancer of the hormones it needs to grow.
Targeted therapies is approved by the U.S. Food and Drug Administration for various types of cancers. This offers significant benefits to treat the cancer such as alter proteins within cancer cells that cause those cells to die, prevent new blood vessels from forming, which cuts off blood supply to tumor, and others. One of the major advantage of targeted therapy is it helps to reduce cancer treatment-related side effects and improved outcomes.
Market Dynamics
Increase in awareness regarding the advanced therapeutics to treat cancer leads to facilitate drug development in precision oncology is likely expected to boost the growth of market. For instance, in May 2021, the U.S. Food and Drug Administration had approved Rybrevant (amivantamab-vmjw) as the first treatment for adult patients with non-small cell lung cancer. Furthermore, key players operating in the market are engaged in focusing on expanding the products pipeline and thereby strengthening the market position. This in turn to drive the growth of market. For instance, Xilio Therapeutics, a biotechnology company entered into a clinical trial collaboration and supply agreement with Merck to evaluate XTX101, Xilio's engineered tumor-selective Fc-enhanced, anti-CTLA-4 monoclonal antibody (mAb) product candidate, in combination with KEYTRUDA.
Key features of the study:
This report provides an in-depth analysis of the global targeted therapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global targeted therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
Key companies covered as a part of this study include Amgen Inc., GlaxoSmithKline plc, Sanofi, Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Novartis AG, Pfizer Inc., F. Hoffmann-La Roche Ltd, AstraZeneca, Seagen Inc., Bayer AG, and Bristol Myers Squibb
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global targeted therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global targeted therapy market
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Application
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Research & Development (R&D) Activities in Targeted Therapy
Medical Uses Of CBD vs THC
Impact Analysis
Market Drivers
Market Restraints
Market Opportunities
Key Developments
Strategic Collaborations & Agreements
Regulatory Scenario
PEST Analysis
Emerging use of Targeted Therapies
4. Global Targeted Therapy Market- Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply and Demand Analysis
Key Developments
5. Global Targeted Therapy Market, By Type, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Small Molecule Medicines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Monoclonal Antibodies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Targeted Therapy Market, By Application, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Breast Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Colorectal Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Leukemia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Lung Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Lymphoma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Renal Cancer
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Targeted Therapy Market, By Distribution Channel, 2017 - 2028, (US$ Mn)
Introduction
Market Share Analysis, 2021 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Targeted Therapy Market, By Region, 2017 - 2028, (US$ Mn)
9. Competitive Landscape
Heat Map Analysis
Market Share Analysis
Amgen Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
GlaxoSmithKline plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Sanofi
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Takeda Pharmaceutical Company Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Merck & Co., Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
F. Hoffmann-La Roche Ltd
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Seagen Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bayer AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Bristol Myers Squibb
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
Analyst Views
10. Section
For more information about this report visit https://www.researchandmarkets.com/r/cqamx2
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900